1 active not recruiting, 1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Lenvatinib 1: new trials by email Literature Review of Lenvatinib 1 trials Research Report on Lenvatinib 1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion HAIC, Lenvatinib, PD-1 Inhibitors - Hepatocellular Carcinoma (HCC) | Active not recruiting | Peking University | 150 | 2026-05-29 | 2026-06-09 | |
| HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT HAIC, Lenvatinib 1, PD-1 Inhibitors - Hepatocellular Carcinoma, Portal Vein Thrombosis | Phase 2 | Completed | Peking University | 66 | 2022-01-10 | 2026-01-23 |
China (2)
Xiaodong Wang (1) · Xiaodong Wang, MD (1)